Drugs / BAT7104
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05200013 | Apr 2022 → Jun 2024 | — | Bio-Thera Solutions | Completed | No outcome recorded |
| Phase 1 | NCT05767060 | Jan 2022 → Dec 2024 | cancer | Bio-Thera Solutions | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAT7104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05200013 ↗ |
| Route | Intravenous | “each dose group is given intravenous infusion” NCT05767060 ↗ |